Your browser doesn't support javascript.
loading
Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre.
Tam, Constantine S; Gregory, Gareth P; Ku, Matthew; Fleming, Shaun; Handunnetti, Sasanka M; Lee, Denise; Walker, Patricia; Perkins, Andrew; Lew, Thomas E; Sirdesai, Shreerang; Chua, Chong Chyn; Gilbertson, Michael; Lasica, Masa; Anderson, Mary Ann; Renwick, William; Grigg, Andrew; Patil, Sush; Opat, Stephen; Friebe, Adam; Cooke, Rachel; De Boer, Jasper; Spencer, Andrew; Ritchie, David; Agarwal, Rishu; Blombery, Piers.
Afiliação
  • Tam CS; Alfred Hospital, Melbourne, Victoria, Australia.
  • Gregory GP; Monash University, Melbourne, Victoria, Australia.
  • Ku M; VCCC Alliance, Melbourne, Victoria, Australia.
  • Fleming S; Monash University, Melbourne, Victoria, Australia.
  • Handunnetti SM; Monash Haematology, Monash Health, Melbourne, Victoria, Australia.
  • Lee D; Department of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia.
  • Walker P; University of Melbourne, Melbourne, Victoria, Australia.
  • Perkins A; Alfred Hospital, Melbourne, Victoria, Australia.
  • Lew TE; Monash University, Melbourne, Victoria, Australia.
  • Sirdesai S; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Chua CC; Department of Haematology, Box Hill Hospital, Melbourne, Victoria, Australia.
  • Gilbertson M; Alfred Hospital, Melbourne, Victoria, Australia.
  • Lasica M; Department of Clinical Haematology, Peninsula Health, Melbourne, Victoria, Australia.
  • Anderson MA; Peninsula Private Hospital, Melbourne, Victoria, Australia.
  • Renwick W; Alfred Hospital, Melbourne, Victoria, Australia.
  • Grigg A; Monash University, Melbourne, Victoria, Australia.
  • Patil S; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Opat S; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Friebe A; Department of Haematology, University Hospital Geelong, Geelong, Victoria, Australia.
  • Cooke R; Alfred Hospital, Melbourne, Victoria, Australia.
  • De Boer J; Department of Clinical Haematology, Northern Health, Melbourne, Victoria, Australia.
  • Spencer A; Monash University, Melbourne, Victoria, Australia.
  • Ritchie D; Monash Haematology, Monash Health, Melbourne, Victoria, Australia.
  • Agarwal R; Department of Haematology and Oncology, Western Health, Melbourne, Victoria, Australia.
  • Blombery P; Department of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia.
Intern Med J ; 52(7): 1286-1287, 2022 07.
Article em En | MEDLINE | ID: mdl-35879233
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Intern Med J Assunto da revista: MEDICINA INTERNA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Intern Med J Assunto da revista: MEDICINA INTERNA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália